◆ 会议时间：2024年4月18日至20日
◆ 会议地点：日本 神户

◆ 会议简介：

2024年第68届日本风湿病学会(JCR)年会将于2024年4月18日至20日在日本神户举行，会议由日本风湿病学会(JCR)主办。

日本风湿病学会(JCR)成立于1957年，日本所有主要科学和医院机构的执业医师、研究科学家和学术学者中，有9964人是日本风湿病学会(JCR)的成员。JCR的宗旨是通过分享风湿病发病机制的知识，来减轻个人和社会对风湿病的负担，从而改善风湿病的治疗、预防和康复。JCR每年春季举办年度科学会议，为风湿病学家和其他专家宣提供一个分享风湿性疾病预防和治疗知识人平台；JCR还举办国际风湿病学研讨会，组织区域教育课程以及先进的讲座等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

JCR 2024
第68回日本リウマチ学会総・学術集会
68th Annual General Assembly and Scientific Meeting of the Japan College of Rheumatology

会期/Date:
2024年4月18日（木）〜 4月20日（土）

会場/Venue:
神戸コンベンションセンター
〒650-0046 神戸市中央区港島中町6-9-1
TEL：078-302-5200

テーマ/Theme:
流心をとる Catch the essence

一般演題登録期間:
2023年9月7（木）～10月26日（木）正午 点此进入>>>
Submission Period: September 7（Thu）- October 26（Thu）2023, 12:00（JST）

Greetings from Congress President

Professor Michiaki Takagi, MD. PhD

Professor and Chairman,
Department of Orthopaedic Surgery,
Yamagata University Faculty of Medicine, Yamagata, Japan

Toward the 68th Annual General Assembly & Scientific Meeting of the Japan College of Rheumatology
-“Ryushin wo toru”(Catch the Essence) - Thoughts on a Theme

The 68th Annual General Assembly & Scientific Meeting of the Japan College of Rheumatology (JCR) will be held at the Kobe Convention Center from April 18 to 20, 2024. It is a great honor for me to be in charge of this meeting, which has a long tradition since 1957, when the Japan Rheumatism Association, the predecessor of the JCR was established.

Looking back on the history of the JCR, our society has always been ahead of the times and the scientific meetings have developed into large gatherings of people from various fields and disciplines. Looking at the world, the past few years have been difficult, with the pandemic of Covid-19, wars, and various other events casting a dark shadow over society as a whole. Even in these times, the JCR has not stopped its progress and has continued to this day. I believe that this is due to the efforts of many of you.

A quarter of a century has passed in the 21st century. In the treatment of rheumatoid arthritis, the advent of biologic and targeted synthetic disease-modifying anti-rheumatic drugs, and a wide range of other drugs has greatly advanced drug therapy, and the improvement in prognosis has been remarkable. The benefits of pharmacotherapy in some other rheumatic diseases, such as spondyloarthritis and systemic lupus erythematosus, are also becoming evident. On the other hand, many rheumatic diseases still have problems of disease activity and quality of life that cannot be controlled by drug therapy, as well as musculoskeletal disorders, including joint destruction, and organ complications. This is a major challenge for the next quarter century. In rheumatoid arthritis, which affects a large number of patients, it will become even more important to deal not only with osteoarticular disorders in aging patients and patients with elderly onset of disease, but also with co-morbid conditions. We expect to develop a more comprehensive and multidisciplinary approach by integrating internal medicine, orthopedics, pediatrics, rehabilitation medicine and other related medical fields, as well as social support. When I review the current situation in Japan, a super-aging society unlike any other in the world, I feel that we are at a crossroads where we need to reconsider the future outlook for rheumatic diseases. At the same time, there are many rheumatic diseases that need to be addressed in each age group in our super-aged, low fertility society, and it is essential to develop rheumatology and medical care that is attentive and balanced from childhood to old age. Taking into account the progress of various science and technology such as AI, IT, Dx, XR/ER, robotics, and regenerative medicine, the development of academic societies with an eye on the future is desired. I hope that each and every one of the participants at the conference, which aims for a higher level, will have a good opportunity to learn the new from the old, and to look beyond the current situation and into the future.

The theme of the 68th JCR Meeting is "Ryushin wo Toru.” Many of you may recall the etymology of the word "rheumatism" from the character for "flow". The word "ryushin wo toru" is derived from a favorite phrase of an experienced fly fisherman in the northern part of Japan. The word "ryushin" means that you have to pass the fly hook firmly through the heart of the stream to meet the upstream salmon, and I superimposed it on the image of "Catch the Essence" to catch the essence of things. Ryushin literally means the center of a river's flow, where it flows most vigorously. However, it is not always in the center of the river, and sometimes it is not easily visible. Today, we have easy access to a vast amount of information and knowledge, and it takes tireless effort to discern and accurately grasp the essence of things from the vast amount of information and knowledge that is available. Creativity and ingenuity are essential. For those of you with enterprising spirit, I hope that the Annual Meeting will be a place for you to disseminate the valuable results of your earnest daily clinical, research, educational, and social activities, and at the same time, to learn new knowledge and skills, deepen your friendship, and strengthen your ties. Through these activities, I sincerely hope that this meeting will further contribute to the development of rheumatology, rheumatology care, and other related fields. In conclusion, I would like to ask for your continued support and cooperation in making this meeting even more fruitful.

注册费：

Registration Fee

Due to recent price increases, we have revised the registration fee for full delegates category from this annual meeting.
Thank you for your understanding.

For JCR members（Tax exemption）

For Non-JCR members（Tax included）

*1 Medical or scientific professionals, clinicians, M.D, PhD

*2 Nurses, physiotherapists, occupational therapists and other health professionals.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。